Thoughts on COVID-19 and autoimmune diseases
Identifieur interne : 000032 ( Pmc/Checkpoint ); précédent : 000031; suivant : 000033Thoughts on COVID-19 and autoimmune diseases
Auteurs : Anca D. Askanase [États-Unis] ; Leila Khalili [États-Unis] ; Jill P. Buyon [États-Unis]Source :
- Lupus Science & Medicine [ 2053-8790 ] ; 2020.
Abstract
Over the 2 months since coronavirus first appeared in China, cases have emerged on every continent, and it is clear that patients with autoimmune diseases might also be affected. Coronavirus disease 2019 (COVID-19) is a highly contagious viral illness with a mortality rate approaching 2%. Here we discuss the challenges that patients with autoimmune diseases might face and the information on using immunomodulatory therapies like chloroquine, tocilizumab and baricitinib to quench the cytokine storm in patients with very severe COVID-19 pneumonia.
Url:
DOI: 10.1136/lupus-2020-000396
PubMed: 32341791
PubMed Central: 7174058
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
PMC:7174058Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Thoughts on COVID-19 and autoimmune diseases</title><author><name sortKey="Askanase, Anca D" sort="Askanase, Anca D" uniqKey="Askanase A" first="Anca D" last="Askanase">Anca D. Askanase</name><affiliation wicri:level="1"><nlm:aff id="aff1"><institution content-type="department">Department of Rheumatology</institution>,<institution>Columbia University Medical Center</institution>,<addr-line content-type="city">New York</addr-line>,<addr-line content-type="state">New York</addr-line>,<country>USA</country></nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea># see nlm:aff country strict</wicri:regionArea></affiliation></author><author><name sortKey="Khalili, Leila" sort="Khalili, Leila" uniqKey="Khalili L" first="Leila" last="Khalili">Leila Khalili</name><affiliation wicri:level="1"><nlm:aff id="aff1"><institution content-type="department">Department of Rheumatology</institution>,<institution>Columbia University Medical Center</institution>,<addr-line content-type="city">New York</addr-line>,<addr-line content-type="state">New York</addr-line>,<country>USA</country></nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea># see nlm:aff country strict</wicri:regionArea></affiliation></author><author><name sortKey="Buyon, Jill P" sort="Buyon, Jill P" uniqKey="Buyon J" first="Jill P" last="Buyon">Jill P. Buyon</name><affiliation wicri:level="1"><nlm:aff id="aff2"><institution content-type="department">Department of Rheumatology</institution>,<institution>NYU Langone Health</institution>,<addr-line content-type="city">New York</addr-line>,<addr-line content-type="state">New York</addr-line>,<country>USA</country></nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea># see nlm:aff country strict</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">32341791</idno><idno type="pmc">7174058</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174058</idno><idno type="RBID">PMC:7174058</idno><idno type="doi">10.1136/lupus-2020-000396</idno><date when="2020">2020</date><idno type="wicri:Area/Pmc/Corpus">000701</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000701</idno><idno type="wicri:Area/Pmc/Curation">000701</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000701</idno><idno type="wicri:Area/Pmc/Checkpoint">000032</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000032</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Thoughts on COVID-19 and autoimmune diseases</title><author><name sortKey="Askanase, Anca D" sort="Askanase, Anca D" uniqKey="Askanase A" first="Anca D" last="Askanase">Anca D. Askanase</name><affiliation wicri:level="1"><nlm:aff id="aff1"><institution content-type="department">Department of Rheumatology</institution>,<institution>Columbia University Medical Center</institution>,<addr-line content-type="city">New York</addr-line>,<addr-line content-type="state">New York</addr-line>,<country>USA</country></nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea># see nlm:aff country strict</wicri:regionArea></affiliation></author><author><name sortKey="Khalili, Leila" sort="Khalili, Leila" uniqKey="Khalili L" first="Leila" last="Khalili">Leila Khalili</name><affiliation wicri:level="1"><nlm:aff id="aff1"><institution content-type="department">Department of Rheumatology</institution>,<institution>Columbia University Medical Center</institution>,<addr-line content-type="city">New York</addr-line>,<addr-line content-type="state">New York</addr-line>,<country>USA</country></nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea># see nlm:aff country strict</wicri:regionArea></affiliation></author><author><name sortKey="Buyon, Jill P" sort="Buyon, Jill P" uniqKey="Buyon J" first="Jill P" last="Buyon">Jill P. Buyon</name><affiliation wicri:level="1"><nlm:aff id="aff2"><institution content-type="department">Department of Rheumatology</institution>,<institution>NYU Langone Health</institution>,<addr-line content-type="city">New York</addr-line>,<addr-line content-type="state">New York</addr-line>,<country>USA</country></nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea># see nlm:aff country strict</wicri:regionArea></affiliation></author></analytic><series><title level="j">Lupus Science & Medicine</title><idno type="eISSN">2053-8790</idno><imprint><date when="2020">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>Over the 2 months since coronavirus first appeared in China, cases have emerged on every continent, and it is clear that patients with autoimmune diseases might also be affected. Coronavirus disease 2019 (COVID-19) is a highly contagious viral illness with a mortality rate approaching 2%. Here we discuss the challenges that patients with autoimmune diseases might face and the information on using immunomodulatory therapies like chloroquine, tocilizumab and baricitinib to quench the cytokine storm in patients with very severe COVID-19 pneumonia.</p></div></front><back><div1 type="bibliography"><listBibl><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Zhang, W" uniqKey="Zhang W">W Zhang</name></author><author><name sortKey="Du, R H" uniqKey="Du R">R-H Du</name></author><author><name sortKey="Li, B" uniqKey="Li B">B Li</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bai, Y" uniqKey="Bai Y">Y Bai</name></author><author><name sortKey="Yao, L" uniqKey="Yao L">L Yao</name></author><author><name sortKey="Wei, T" uniqKey="Wei T">T Wei</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Niewold, Tb" uniqKey="Niewold T">TB Niewold</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Yee, Am" uniqKey="Yee A">AM Yee</name></author><author><name sortKey="Buyon, Jp" uniqKey="Buyon J">JP Buyon</name></author><author><name sortKey="Yip, Yk" uniqKey="Yip Y">YK Yip</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Preble, O" uniqKey="Preble O">O Preble</name></author><author><name sortKey="Black, R" uniqKey="Black R">R Black</name></author><author><name sortKey="Friedman, R" uniqKey="Friedman R">R Friedman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Pene, F" uniqKey="Pene F">F Pene</name></author><author><name sortKey="Merlat, A" uniqKey="Merlat A">A Merlat</name></author><author><name sortKey="Vabret, A" uniqKey="Vabret A">A Vabret</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chen, N" uniqKey="Chen N">N Chen</name></author><author><name sortKey="Zhou, M" uniqKey="Zhou M">M Zhou</name></author><author><name sortKey="Dong, X" uniqKey="Dong X">X Dong</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Pan, F" uniqKey="Pan F">F Pan</name></author><author><name sortKey="Ye, T" uniqKey="Ye T">T Ye</name></author><author><name sortKey="Sun, P" uniqKey="Sun P">P Sun</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Xu, Z" uniqKey="Xu Z">Z Xu</name></author><author><name sortKey="Shi, L" uniqKey="Shi L">L Shi</name></author><author><name sortKey="Wang, Y" uniqKey="Wang Y">Y Wang</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Wang, M" uniqKey="Wang M">M Wang</name></author><author><name sortKey="Cao, R" uniqKey="Cao R">R Cao</name></author><author><name sortKey="Zhang, L" uniqKey="Zhang L">L Zhang</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Yao, X" uniqKey="Yao X">X Yao</name></author><author><name sortKey="Ye, F" uniqKey="Ye F">F Ye</name></author><author><name sortKey="Zhang, M" uniqKey="Zhang M">M Zhang</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Liu, J" uniqKey="Liu J">J Liu</name></author><author><name sortKey="Cao, R" uniqKey="Cao R">R Cao</name></author><author><name sortKey="Xu, M" uniqKey="Xu M">M Xu</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gao, J" uniqKey="Gao J">J Gao</name></author><author><name sortKey="Tian, Z" uniqKey="Tian Z">Z Tian</name></author><author><name sortKey="Yang, X" uniqKey="Yang X">X Yang</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gautret, P" uniqKey="Gautret P">P Gautret</name></author><author><name sortKey="Lagier, J" uniqKey="Lagier J">J Lagier</name></author><author><name sortKey="Parola, P" uniqKey="Parola P">P Parola</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chen, J" uniqKey="Chen J">J Chen</name></author><author><name sortKey="Liu, D" uniqKey="Liu D">D Liu</name></author><author><name sortKey="Liu, L" uniqKey="Liu L">L Liu</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Channappanavar, R" uniqKey="Channappanavar R">R Channappanavar</name></author><author><name sortKey="Perlman, S" uniqKey="Perlman S">S Perlman</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Richardson, P" uniqKey="Richardson P">P Richardson</name></author><author><name sortKey="Griffin, I" uniqKey="Griffin I">I Griffin</name></author><author><name sortKey="Tucker, C" uniqKey="Tucker C">C Tucker</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Stebbing, J" uniqKey="Stebbing J">J Stebbing</name></author><author><name sortKey="Phelan, A" uniqKey="Phelan A">A Phelan</name></author><author><name sortKey="Griffin, I" uniqKey="Griffin I">I Griffin</name></author></analytic></biblStruct></listBibl></div1></back></TEI><pmc article-type="letter"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Lupus Sci Med</journal-id><journal-id journal-id-type="iso-abbrev">Lupus Sci Med</journal-id><journal-id journal-id-type="hwp">lupusscimed</journal-id><journal-id journal-id-type="publisher-id">lupus</journal-id><journal-title-group><journal-title>Lupus Science & Medicine</journal-title></journal-title-group><issn pub-type="epub">2053-8790</issn><publisher><publisher-name>BMJ Publishing Group</publisher-name><publisher-loc>BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">32341791</article-id><article-id pub-id-type="pmc">7174058</article-id><article-id pub-id-type="publisher-id">lupus-2020-000396</article-id><article-id pub-id-type="doi">10.1136/lupus-2020-000396</article-id><article-categories><subj-group subj-group-type="heading"><subject>Letter</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>1506</subject></subj-group></article-categories><title-group><article-title>Thoughts on COVID-19 and autoimmune diseases</article-title></title-group><contrib-group><contrib id="author-46253668" contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-4597-5023</contrib-id><name><surname>Askanase</surname><given-names>Anca D</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Khalili</surname><given-names>Leila</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib id="author-62014697" contrib-type="author"><name><surname>Buyon</surname><given-names>Jill P</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib></contrib-group><aff id="aff1"><label>1</label><institution content-type="department">Department of Rheumatology</institution>,<institution>Columbia University Medical Center</institution>,<addr-line content-type="city">New York</addr-line>,<addr-line content-type="state">New York</addr-line>,<country>USA</country></aff><aff id="aff2"><label>2</label><institution content-type="department">Department of Rheumatology</institution>,<institution>NYU Langone Health</institution>,<addr-line content-type="city">New York</addr-line>,<addr-line content-type="state">New York</addr-line>,<country>USA</country></aff><author-notes><corresp><label>Correspondence to</label> Dr Anca D Askanase; <email>ada20@cumc.columbia.edu</email></corresp></author-notes><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>3</day><month>4</month><year>2020</year></pub-date><volume>7</volume><issue>1</issue><elocation-id>e000396</elocation-id><history><date date-type="received"><day>17</day><month>3</month><year>2020</year></date><date date-type="accepted"><day>20</day><month>3</month><year>2020</year></date></history><permissions><copyright-statement>© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><ali:license_ref start_date="2020-04-03">http://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="lupus-2020-000396.pdf"></self-uri><abstract><p>Over the 2 months since coronavirus first appeared in China, cases have emerged on every continent, and it is clear that patients with autoimmune diseases might also be affected. Coronavirus disease 2019 (COVID-19) is a highly contagious viral illness with a mortality rate approaching 2%. Here we discuss the challenges that patients with autoimmune diseases might face and the information on using immunomodulatory therapies like chloroquine, tocilizumab and baricitinib to quench the cytokine storm in patients with very severe COVID-19 pneumonia.</p></abstract><kwd-group><kwd>autoimmune diseases</kwd><kwd>inflammation</kwd><kwd>cytokines</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>special-feature</meta-name><meta-value>unlocked</meta-value></custom-meta></custom-meta-group></article-meta></front></pmc><affiliations><list><country><li>États-Unis</li></country></list><tree><country name="États-Unis"><noRegion><name sortKey="Askanase, Anca D" sort="Askanase, Anca D" uniqKey="Askanase A" first="Anca D" last="Askanase">Anca D. Askanase</name></noRegion><name sortKey="Buyon, Jill P" sort="Buyon, Jill P" uniqKey="Buyon J" first="Jill P" last="Buyon">Jill P. Buyon</name><name sortKey="Khalili, Leila" sort="Khalili, Leila" uniqKey="Khalili L" first="Leila" last="Khalili">Leila Khalili</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Pmc/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000032 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd -nk 000032 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TocilizumabV1
|flux= Pmc
|étape= Checkpoint
|type= RBID
|clé= PMC:7174058
|texte= Thoughts on COVID-19 and autoimmune diseases
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/RBID.i -Sk "pubmed:32341791" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a TocilizumabV1
| This area was generated with Dilib version V0.6.34. |  |